Volume 1, Issue 11: New OAD Insights
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 1, Issue 11)
Target Audience
Nurses and health care professionals involved in the care of patients with diabetes.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Summarize the glycemic and nonglycemic effects of SGLT-2 inhibitors.
- Describe the recent data on the use of SGLT-2 inhibitors in dual and triple therapy, as well as in combination with insulin.
- Discuss the safety implications of recent clinical trials with DPP-4 inhibitors.
Nestoras Mathioudakis, MD
Assistant Professor of Medicine
Division of Endocrinology, Diabetes, & Metabolism
Associate Director, Inpatient Diabetes Management Service Program
Johns Hopkins University School of Medicine
Baltimore, Maryland
Om Ganda, MD
Associate Clinical Professor of Medicine
Senior Physician and Director, Lipid Clinic
Chair, Clinical Oversight Committee
Joslin Diabetes Center
Boston, Massachusetts
Available Credit
- 1.00 ANCC
- 1.00 Attendance